COVID-19 PET RCT
- Home
- Canada
- Montreal, QC
- COVID-19 PET RCT
This is a clinical trial looking at hydroxychloroquine versus placebo for effectiveness in preventin
Address
1001 Decarie Boulevard
Montreal, QC
H4A3J1
Website
Alerts
Be the first to know and let us send you an email when COVID-19 PET RCT posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Shortcuts
Share
Category
COVID-19 PEP TRIAL
COVID-19 (Coronavirus disease 2019), is an infection caused by the virus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). We are recruiting adults in Quebec, Alberta and Manitoba who have have a confirmed diagnosis of COVID-19, or are a household member exposed to a person who has COVID-19, or are a healthcare worker who had a high risk exposure to a COVID-19 case.
This study is comparing the drug hydroxychloroquine to placebo to determine if it is effective in preventing the onset or progression of COVID-19 disease. Hydroxychloroquine is approved by Health Canada for the treatment of diseases like rheumatoid arthritis, lupus, and acute attacks of malaria. There is some evidence that hydroxychloroquine may be helpful to reduce the symptoms of COVID-19 disease, but we don’t really know at this time. An urgent clinical trial is needed so we know if this drug should be used routinely or not.
Click here for more information on hydroxychloroquine:
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70886
